Kwality Pharmaceuticals Limited (BOM:539997)
3,396.75
+80.05 (2.41%)
At close: Oct 16, 2026
Kwality Pharmaceuticals Employees
Kwality Pharmaceuticals had 1,137 employees as of March 31, 2026. The number of employees increased by 140 or 14.04% compared to the previous year. That makes Kwality Pharmaceuticals the 13,951st largest employer in the world and 1,045th in India.
Employees
1,137
Change (1Y)
140
Growth (1Y)
14.04%
Revenue / Employee
4.87M INR
Profits / Employee
712.80K INR
Market Cap
35.25B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 1,137 | 140 | 14.04% |
| Mar 31, 2025 | 997 | 191 | 23.70% |
| Mar 31, 2024 | 806 | 227 | 39.21% |
| Mar 31, 2023 | 579 | 39 | 7.22% |
| Dec 31, 2022 | 1,500 | 960 | 177.78% |
| Sep 30, 2022 | 1,500 | - | - |
| Jun 30, 2022 | 1,500 | 1,004 | 202.42% |
| Mar 31, 2022 | 540 | 44 | 8.87% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| FDC Limited | 7,076 |
| Unichem Laboratories | 2,780 |
| Hikal | 2,152 |
| Morepen Laboratories | 1,919 |
| Gufic Biosciences | 1,607 |
| Venus Remedies | 1,472 |
| Sanofi India | 1,097 |
| Syncom Formulations (India) | 902 |
Kwality Pharmaceuticals News
- 2 months ago - Kwality Pharmaceuticals Transcript: Q1 26/27 - Transcripts
- 2 months ago - Kwality Pharmaceuticals Quarterly report: Q1 2027 - Filings
- 2 months ago - Kwality Pharmaceuticals Slides: Q1 2027 - Filings
- 5 months ago - Kwality Pharmaceuticals Quarterly report: Q4 2026 - Filings
- 5 months ago - Kwality Pharmaceuticals Annual report: Q4 2026 - Filings
- 8 months ago - Kwality Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 8 months ago - Kwality Pharmaceuticals Slides: Q3 2026 - Filings
- 11 months ago - Kwality Pharmaceuticals Quarterly report: Q2 2026 - Filings